1. Home
  2. FOXF vs CTMX Comparison

FOXF vs CTMX Comparison

Compare FOXF & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fox Factory Holding Corp.

FOXF

Fox Factory Holding Corp.

HOLD

Current Price

$17.58

Market Cap

618.2M

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$5.40

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOXF
CTMX
Founded
2007
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Motor Vehicles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
618.2M
596.2M
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
FOXF
CTMX
Price
$17.58
$5.40
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$30.67
$8.86
AVG Volume (30 Days)
571.4K
2.9M
Earning Date
05-29-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,467,321,000.00
$138,103,000.00
Revenue This Year
$5.16
N/A
Revenue Next Year
$4.34
N/A
P/E Ratio
N/A
$22.58
Revenue Growth
5.27
36.45
52 Week Low
$13.08
$0.40
52 Week High
$31.18
$6.35

Technical Indicators

Market Signals
Indicator
FOXF
CTMX
Relative Strength Index (RSI) 40.59 50.09
Support Level $17.50 $5.10
Resistance Level $17.98 $6.25
Average True Range (ATR) 1.09 0.33
MACD -0.26 -0.06
Stochastic Oscillator 37.67 33.18

Price Performance

Historical Comparison
FOXF
CTMX

About FOXF Fox Factory Holding Corp.

Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: